Coronavirus: U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mozambique
September 27, 2021 at 04:33 am EDT
Share
MAPUTO, Mozambique, September 24, 2021/APO Group/ -- Today, at the Mavalane International Airport in Maputo, the United States government donated 336,000 doses of the Johnson & Johnson COVID-19 vaccine to the Mozambican Ministry of Health. Because the vaccine confers immunity in a single dose, this shipment will provide immunity to 336,000 Mozambicans, protecting the health of Mozambicans and preventing dangerous new variants from spreading. Since the storage of Johnson & Johnson vaccines is less onerous than other vaccines, they are easier to distribute.
Our two governments have worked together in a variety of ways to curb COVID-19 in Mozambique
U.S. Ambassador Dennis W. Hearne stated: "As the largest bi-lateral donor of vaccines to Mozambique, the United States is pleased to be part of this coordinated global effort to bring life-saving support to the people of Mozambique. Our two governments have worked together in a variety of ways to curb COVID-19 in Mozambique. These vaccines will fill an important need to successfully fight the virus."
This is the second COVID-19 vaccine delivery. In July, the United States donated 302,400 Johnson and Johnson vaccines. This assistance is another example of the strength of the U.S.-Mozambique relationship, building on decades of health cooperation between Mozambique and the United States. The U.S. Government has provided early and ongoing support for Mozambique's response to the COVID-19 pandemic, including assistance valued at $62.5 million. This assistance includes 50 ventilators donated to the Mozambican Ministry of Health in 2020, personal protective equipment for healthcare workers, laboratory and oxygen equipment, training, and funding for increased medical staff, among other initiatives. For more information on U.S. support for Mozambique's efforts to combat COVID-19, visit this link.
The United States is committed to leading the global COVID-19 response because it is the right thing to do and will make the world safer. The U.S. Government committed $4 billion to the COVAX Facility, becoming the largest donor to the global effort to vaccinate people around the world. The U.S. Government has also purchased one billion vaccines for low-income countries and donated 80 million vaccines from the United States' own supply. For more information on the U.S. government's new Covid commitments, visit this link.
In close collaboration with the Government of the Republic of Mozambique, the U.S. Government provides more than $500 million in annual assistance to improve the quality of education and healthcare, promote economic prosperity, and support the overall development of the nation.
Distributed by APO Group on behalf of U.S. Embassy in Mozambique.
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;
- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;
- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.
At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).
Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).